Small-Cap Momentum Watch: Upcoming Catalysts for May 26–29
5/25/20267 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.
--
Companies Presenting at EASL Congress 2026
EASL Congress 2026 will take place May 27–30, 2026, at Fira Barcelona Gran Via in Barcelona, Spain, with hybrid in-person and online participation. The event is Europe’s largest hepatology congress, bringing together clinicians, researchers, allied health professionals, patients, and industry partners to discuss liver disease research, clinical advances, and emerging therapies.
Participating companies include: ● PRQR • AVIR • MTVA • GALT • CMMB
Companies Participating in the 23rd Annual Craig-Hallum Institutional Investor Conference
The 23rd Annual Craig-Hallum Institutional Investor Conference will take place on Thursday, May 28, 2026, at the Depot Renaissance Hotel in Minneapolis, Minnesota. The event focuses on small- and mid-cap equities, with structured one-on-one meetings between institutional investors and management teams from public companies.
Participating companies include: ● MDXG • PYPD • CREX • SWIM • ALTO • AIOT
Companies Participating in the TD Cowen 7th Annual Oncology Innovation Summit
The TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA is scheduled for May 26–27, 2026. The event will feature multiple sessions across the two days focused on oncology innovation, ASCO and EHA-related insights, company updates, and investor discussions.
Participating companies include: ● ACRV • PEPG • TARA • CCCC ● NUVB • ZNTL • WHWK
Companies Participating in the Lytham Partners Spring 2026 Investor Conference
The Lytham Partners Spring 2026 Investor Conference will take place virtually on Thursday, May 28, 2026. The event will feature company webcast presentations, interactive sessions, and virtual one-on-one meetings between corporate management teams and registered investors.
Participating companies include: ● JAGX • DYAI • BFRI • IPM ● CVKD • SNES • POCI • AYTU
Companies Presenting at the American Society of Clinical Oncology (ASCO) Annual Meeting
The 2026 ASCO Annual Meeting will take place from May 29 to June 2, 2026, at McCormick Place in Chicago, Illinois, with virtual attendance options available. The program begins Friday, May 29 at 1:00 PM CT and concludes Tuesday, June 2 at 12:45 PM CT. The event will feature more than 200 sessions, over 7,000 scientific abstracts, industry exhibits, poster presentations, Innovation Zone programming, and networking opportunities across oncology-focused communities of practice.
Participating companies include: ● ONCY • BCTX • BLRX • CATX • PLRX • AUTL ● MBRX • APRE • CMPX • BCYC • FATE • BYSI ● CCCC • OABI • CLRB • BDTX • REPL • RNXT ● GNPX • IMMP • XBIO • AGEN • CRDF • INO
Other companies with material events this week:
PROP - Senior management will participate in the 26th Annual Louisiana Energy Conference, being held May 26–28, 2026, at the Four Seasons in New Orleans, Louisiana.
LPCN - Phase 3 clinical data for LPCN 1154 were selected for oral and poster presentations at the 2026 American Society of Clinical Psychopharmacology Annual Meeting, taking place May 26–29, 2026, in Miami, Florida.
BGL - Will host an investor webinar on May 26, 2026, at 11:00 a.m. ET. CEO Andrew Cavaghan will discuss Blue Gold’s mine-to-wallet strategy, new corporate website, and development of the Standard Gold Coin and STANDARD wallet ecosystem.
HITI - Raj Grover will participate at Cannabis Europa in London on May 26, 2026, in the session “Deal Flow & Due Diligence: Inside Europe’s Next M&A Wave.”
STSS - Announced a strategic collaboration to strengthen Solana’s institutional infrastructure. STSS will delegate a portion of its SOL treasury holdings to Stakin by The Tie, and The Tie will host Innovate Miami on May 26, 2026.
EQ - Will host a virtual investor event on May 27, 2026, at 11:00 a.m. ET, featuring new preclinical data on AhR modulators and the relationship between AhR activation and miR-124 induction.
CFND - Executive management will attend Benchmark’s Digital Assets Summit on May 27, 2026, followed by a non-deal roadshow in New York City on May 28–29, 2026.
FRMM - Chairman and CEO McAndrew Rudisill and SVP John Kristoff are expected to participate in the Benchmark Digital Assets Summit on May 27, 2026, in New York.
HTOO - Will release an investor update video and presentation on May 27, 2026, covering recent progress, operational priorities, 2026 milestones, the Royal Uranium acquisition agreement, and its diversified energy platform strategy.
GTN - Will participate in the 11th Annual Goldman Sachs Leveraged Finance Conference on May 27, 2026, in Dana Point, California.
TBLA - Will participate in the TD Cowen Tech, Media and Telecom Conference on May 27, 2026, with a fireside chat scheduled for 3:35 p.m. ET.
HOVR - Will participate in CANSEC 2026, taking place May 27–28, 2026, at the EY Centre in Ottawa.
HYPD - Will participate in Chardan’s Crypto Salon: Believe the HYPE! on May 27, 2026, in New York.
RMNI - Will participate in TD Cowen’s 54th Annual Technology, Media & Telecom Conference on May 27, 2026, in New York City.
KOPN - Will host its Minneapolis Technology Demo Day on May 27, 2026, as part of its 2026 Technology Demo Days Tour.
NCPL - Will host a business update conference call on May 28, 2026, at 4:30 p.m. ET. CEO Todd Violette will discuss Netcapital’s strategic direction, business transformation, near-term priorities, and private capital markets platform.
FFAI - Will present at the Centurion One Capital Inaugural Miami Summit on May 28, 2026, at the Faena Forum in Miami Beach. Global Executive Chairman Jerry Wang will present and participate in investor meetings and panel discussions.
WETO - Will host its inaugural product launch event on May 28, 2026, in Austin, Texas, to launch Orchestra, the Company’s Physical AI operating system.
OABI - Management will hold virtual one-on-one and small group investor meetings at the Benchmark 6th Annual Healthcare House Call Virtual Investor Conference on May 28, 2026.
NWL - Declared a quarterly cash dividend of $0.07 per share, payable June 15, 2026, to common stockholders of record as of May 29, 2026.
MNKD - Afrezza has a pediatric indication PDUFA target action date of May 29, 2026. If approved, it would be the first and only inhaled insulin option for children and adolescents living with diabetes.
STKE - Entered into a definitive agreement to acquire HoudiniSwap LLC for $18 million in cash, shares, a promissory note, and warrants, with closing expected on or before May 29, 2026, subject to customary conditions including CSE approval.
MOLN - Will present at Antibody & Engineering Therapeutics, taking place May 27–29, 2026, in Basel, Switzerland. The presentation, “Radio-DARPins for targeted alpha therapy: first in human insights with MP0712 and opportunities for future candidates,” is scheduled for May 29 at 4:45–5:15 p.m. local time.
TOMZ - Recently executed a non-binding LOI to merge with Carbonium Core, a U.S.-based producer of nuclear-grade graphite for advanced reactor technologies and AI data center infrastructure. Definitive agreements are expected on or before May 30, 2026, subject to due diligence and stockholder approval.
ATNM - Will present three abstracts at the SNMMI 2026 Annual Meeting, taking place May 30–June 2, 2026, in Los Angeles. One presentation, “Optimizing Chelator-to-Antibody Ratio Improves Tumor Targeting and Pharmacokinetics of 225Ac-Labeled Antibodies,” is scheduled for May 31, 2026, from 7:30–8:00 p.m. PT.
LBGJ - Its subsidiary entered into a new equity transfer agreement to acquire a 51% equity interest in Suzhou Yufengyuan Food Distribution Co., Ltd., with closing expected on or before May 30, 2026. The new agreement removes the prior special voting arrangement to enhance purchaser control.
ALP - GAMEE acquisition is projected to close by May 31, 2026, pending final audits of GAMEE HK and Czech Republic. The company also highlighted continued growth of strategic partnerships including Telegram Cocoon, Animoca Brands, and Midnight Network.
BCHT - Will participate in the American Society for Mass Spectrometry 2026 Conference, taking place May 31–June 4, 2026, in San Diego. Dr. Nicholas Lentz will speak during the Agilent Technologies User Group Meeting on May 31 and participate in a technical poster Q&A session on June 3.
SXTP - Submitted a New Dietary Ingredient Notification to the FDA for Australian Chestnut Extract. The FDA has until May 25, 2026, to object, after which the Company would be free to market its planned dietary supplement.
OCGN - Will participate in the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026, from 10:30–10:55 a.m. EDT.
SGHT - Will participate in the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026, at 9:00 a.m. PT / 12:00 p.m. ET.
DGNX - Extended the outside date for completion of its proposed all-share acquisition of Resulticks, valued at $1.5 billion, to May 31, 2026, as both parties finalize financing arrangements and remaining closing workstreams.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.